Taken together, our findings indicate that abnormal expression of PRMT5 is closely related to the lung tumor stages and survival rates in patients with lung cancer, and PRMT5 may regulate angiogenesis, metastasis, and EMT through HIF-1α and PI3K/Akt signaling pathway. This evidence concerns the gene HIF1A and lung carcinoma.